Applied DNA Sciences Inc. has announced a 1-for-15 reverse stock split of its common stock, effective June 2, 2025. The company's shares will begin trading on a split-adjusted basis on Nasdaq under the symbol "APDN" from that date. This move is intended to help the company comply with Nasdaq's $1.00 minimum bid price requirement. The number of outstanding shares will reduce from approximately 7.8 million to about 519 thousand, with no change in the total authorized shares.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.